Kazemi Jaliseh Hadighe, Ramezani Tehrani Fahimeh, Behboudi-Gandevani Samira, Hosseinpanah Farhad, Khalili Davood, Cheraghi Leila, Azizi Fereidoun
Reproductive Health Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Reproductive Endocrinology Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Fertil Steril. 2017 Dec;108(6):1078-1084. doi: 10.1016/j.fertnstert.2017.09.004.
To study the incidence rate and hazard ratios of diabetes and prediabetes between women with PCOS and healthy subjects.
Prospective population-based study.
Not applicable.
PATIENT(S): Women with PCOS (n = 178) and eumenorrheic, nonhirsute, healthy women as controls (n = 1,524), all followed for a median time of 12.9 years.
INTERVENTION(S): None.
MAIN OUTCOME MEASURE(S): Incidence rate and hazard ratios of diabetes and prediabetes between women with PCOS and healthy controls.
RESULT(S): We analyzed the participants on two pathways. First, for detecting new diabetes mellitus (DM) events, we selected participants who were free of DM at baseline (n = 39). Second, for detecting new pre-DM events, we selected participants who were free of pre-DM and DM at baseline (n = 222) from the baseline population. The rest of the population were included for final analysis to calculate the incidence rates and hazard ratio of diabetes and prediabetes events. The incidence rates of diabetes were 12.9 and 4.9 per 1,000 person-years for PCOS and controls, respectively. This incidence rate in women younger than 40 with and without PCOS was 13.4 and 4.2, respectively. The adjusted hazard ratio (HR) for women ≤40 was 4.9 (95% confidence interval [CI], 2.5-9.3). There were no statistically significant differences between the two groups studied after age 40. The incidence rates of prediabetes were 29.7 and 25.9 per 1,000 person-years for PCOS and healthy women, respectively. The incidence rate in women younger than 40 with and without PCOS was 30.3 and 23.9, respectively. The adjusted HR for women ≤40 years, 1.7 (95% CI, 1.1-2.6), disappeared after age 40.
CONCLUSION(S): These data suggest that routine screening for diabetes in prevention strategies does not need to be emphasized for PCOS patients at late reproductive ages if they have not been affected by glucose intolerance up to that point.
研究多囊卵巢综合征(PCOS)女性与健康受试者中糖尿病和糖尿病前期的发病率及风险比。
基于人群的前瞻性研究。
不适用。
PCOS女性(n = 178)和月经正常、无多毛的健康女性作为对照(n = 1524),所有患者随访中位时间为12.9年。
无。
PCOS女性与健康对照者中糖尿病和糖尿病前期的发病率及风险比。
我们通过两条途径分析参与者。首先,为检测新的糖尿病(DM)事件,我们选择基线时无DM的参与者(n = 39)。其次,为检测新的糖尿病前期事件,我们从基线人群中选择基线时无糖尿病前期和DM的参与者(n = 222)。其余人群纳入最终分析以计算糖尿病和糖尿病前期事件的发病率及风险比。PCOS组和对照组的糖尿病发病率分别为每1000人年12.9例和4.9例。40岁及以下有和无PCOS的女性中,这一发病率分别为13.4例和4.2例。40岁及以下女性的调整后风险比(HR)为4.9(95%置信区间[CI],2.5 - 9.3)。40岁以后,两组之间无统计学显著差异。PCOS女性和健康女性的糖尿病前期发病率分别为每1000人年29.7例和25.9例。40岁及以下有和无PCOS的女性中,发病率分别为30.3例和23.9例。40岁及以下女性的调整后HR为1.7(95% CI,1.1 - 2.6),40岁以后消失。
这些数据表明,如果生殖后期的PCOS患者截至当时未受葡萄糖不耐受影响,那么在预防策略中无需强调对其进行糖尿病的常规筛查。